Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 2009 Nov;158(Suppl 1):S121. doi: 10.1111/j.1476-5381.2009.00502_8.x

ZAC (zinc-activated channel)

PMCID: PMC2884622

Overview: The zinc-activated channel [ZAC, nomenclature as agreed by the NC-IUPHAR Subcommittee for the zinc activated channel (Hales and Peters 2009)] is a member of the Cys-loop family that includes the nicotinic acetylcholine, 5-HT3, GABAA and strychnine-sensitive glycine receptors (Davies et al., 2003; Houtani et al., 2005). The channel is likely to exist as a homopentamer of 4TM subunits that form an intrinsic cation-selective channel displaying constitutive activity that can be blocked by (+)-tubocurarine (Davies et al., 2003). ZAC is present in the human, chimpanzee, dog, cow and opossum genomes, but is functionally absent from mouse, or rat, genomes (Davies et al., 2003; Houtani et al., 2005).

Nomenclature ZAC
Ensembl ID ENSG00000186919
Selective agonists (pEC50) Zn2+ (3.3)
Selective antagonists (pIC50) (+)-Tubocurarine (5.2)
Functional characteristics Outwardly rectifying current (both constitutive and evoked by Zn2+)

References

  1. Davies PA, et al. J Biol Chem. 2003;278:712–717. doi: 10.1074/jbc.M208814200. [DOI] [PubMed] [Google Scholar]
  2. Hales TG, Peters JA. http://www.iuphar-db.org/IC/FamilyIntroductionForward?familyId=6.
  3. Houtani T, et al. Biochem Biophys Res Commun. 2005;335:277–285. doi: 10.1016/j.bbrc.2005.07.079. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES